Journal of Cutaneous Oncology
About
Current Issue
Editorials
Perspectives on the Science
Past Issues
Editorial Team
An open-access, peer-reviewed journal dedicated to the advancement of research and education in cutaneous oncology.
Author
Society of Cutaneous Oncology
Current Issue
Editorials
Articles
Perspectives on the Science
Order By
Default
Title
Author
Evolving Standards for Resected High-Risk CSCC: Integrating Insights from C-POST and KEYNOTE-630
This perspective summarizes a multidisciplinary discussion of the C-POST trial, which demonstrated improved disease-free survival with adjuvant cemiplimab in patients with resected high-risk cutaneous squamous cell carcinoma (CSCC). Participants reflected on evolving practice patterns and considered the contrasting futility outcome of adjuvant pembrolizumab in the KEYNOTE-630 study. To help explore potential reasons for these divergent results, this piece incorporates reconstructed survival data—estimates derived from published Kaplan-Meier curves in the absence of individual patient data. The discussion underscores both the enthusiasm and the remaining uncertainty surrounding adjuvant immunotherapy in CSCC.
David Michael Miller, MD, PhD, Vishal Anil Patel, MD, Vernon Keith Sondak, MD, Vatche Tchekmedyian, MD, Ross David Merkin, MD, Isaac Brownell, MD, PhD, Reed E. Drews, MD, Sameer Gupta MD, Nikhil I. Khushalani, MD, Paul T. Nghiem, MD, PhD, Howard Lane Kaufman MD, Kevin Scott Emerick MD
No matching items
↑ Top